316-330 of 440
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
COVID-19: On The FrontlinesChloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Alternative Solutions to the PPE Shortage: Are They Enough?
COVID-19: On The FrontlinesAlternative Solutions to the PPE Shortage: Are They Enough?
Enlisting Students in the Fight Against COVID-19: Helpful or Harmful?
COVID-19: On The FrontlinesEnlisting Students in the Fight Against COVID-19: Helpful or Harmful?
Separating Fact from Fiction: Novel Coronavirus Myths
Clinician's RoundtableSeparating Fact from Fiction: Novel Coronavirus Myths
- advertisement
An In-Depth Look at the Evolution of Cystic Fibrosis Treatments
Clinician's RoundtableAn In-Depth Look at the Evolution of Cystic Fibrosis Treatments
The Harsh Truth Behind the Vaping Epidemic
Clinician's RoundtableThe Harsh Truth Behind the Vaping Epidemic
What’s New in COPD Care: Updates to the GOLD Guidelines & Other Advances
Deep Breaths: Updates from CHESTWhat’s New in COPD Care: Updates to the GOLD Guidelines & Other Advances
Singling Out Severe Asthma: New Breakthroughs in Treatment
Deep Breaths: Updates from CHESTSingling Out Severe Asthma: New Breakthroughs in Treatment
Catching Cystic Fibrosis: Key Diagnostic & Management Updates
Deep Breaths: Updates from CHESTCatching Cystic Fibrosis: Key Diagnostic & Management Updates
Initiating the Right Interstitial Lung Disease Treatment Approach
Deep Breaths: Updates from CHESTInitiating the Right Interstitial Lung Disease Treatment Approach
- advertisement
The Real Cost of Smoking: Medical, Financial, and Societal Considerations
Primary Care TodayThe Real Cost of Smoking: Medical, Financial, and Societal Considerations
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Drug Information UpdatesFDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
